Related references
Note: Only part of the references are listed.Exosome-Mediated Response to Cancer Therapy: Modulation of Epigenetic Machinery
Mohammad Imran Khan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Osteosarcoma
Bree R. Eaton et al.
PEDIATRIC BLOOD & CANCER (2021)
Trastuzumab deruxtecan in previously treated HER2-positive metastatic breast cancer: Plain language summary of the DESTINY-Breast01 study
Shanu Modi
FUTURE ONCOLOGY (2021)
The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
Isabelle Corre et al.
CELLS (2020)
Osteosarcoma: A comprehensive review of management and treatment strategies
Farzaneh Jafari et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
Genome-Informed Targeted Therapy for Osteosarcoma
Leanne C. Sayles et al.
CANCER DISCOVERY (2019)
Incidence and Mortality of Sarcomas in Shanghai, China, During 2002-2014
Bao Pingping et al.
FRONTIERS IN ONCOLOGY (2019)
A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro
Hongxiang Wei et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Promoting Role of MXene Nanosheets in Biomedical Sciences: Therapeutic and Biosensing Innovations
Mohammadreza Soleymaniha et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer
Tingting Li et al.
ACTA BIOMATERIALIA (2019)
Vincristine-loaded hydroxyapatite nanoparticles as a potential delivery system for bone cancer therapy
Ana Luiza Chaves Maia et al.
JOURNAL OF DRUG TARGETING (2018)
Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment
Marina Martinez-Carmona et al.
ACTA BIOMATERIALIA (2018)
Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
Fateme Haghiralsadat et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Progress in the chemotherapeutic treatment of osteosarcoma
Ya Zhang et al.
ONCOLOGY LETTERS (2018)
Safety of novel liposomal drugs for cancer treatment: Advances and prospects
Keyu He et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models
Yingying Chi et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Livia Palmerston Mendes et al.
MOLECULES (2017)
Liposomal Formulations in Clinical Use: An Updated Review
Upendra Bulbake et al.
PHARMACEUTICS (2017)
Gold nanoconjugates reinforce the potency of conjugated cisplatin and doxorubicin
Sana Iram et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Advances in Micelle-based Drug Delivery: Cross-linked Systems
Ismail Alper Isoglu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Future directions in the treatment of osteosarcoma
Michael W. Bishop et al.
CURRENT OPINION IN PEDIATRICS (2016)
Immunological off-target effects of imatinib
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion
Margherita Cortini et al.
PLOS ONE (2016)
Stimuli-responsive dendrimers in drug delivery
Hui Wang et al.
BIOMATERIALS SCIENCE (2016)
Exosomes Released by Melanoma Cells Prepare Sentinel Lymph Nodes for Tumor Metastasis
Joshua L. Hood et al.
CANCER RESEARCH (2011)
Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts
Jan C. Brune et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez-Erviti et al.
NATURE BIOTECHNOLOGY (2011)
Gefitinib A Review of its Use in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer
Mark Sanford et al.
DRUGS (2009)
Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging
Shannon Kidd et al.
STEM CELLS (2009)
Proteomic profiling of exosomes: Current perspectives
Richard J. Simpson et al.
PROTEOMICS (2008)
Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index
P Jalava et al.
HISTOPATHOLOGY (2006)
Share Paper
